TLCM
GILD icon

Twin Lakes Capital Management’s Gilead Sciences GILD Stock Holding History

Twin Lakes Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.36M Buy
58,267
+165
+0.3% +$21.7K 2.81% 5
2026
Q1 		$8.1M Sell
58,102
-652
-1% -$91.3K 3.68% 4
2025
Q4 		$7.21M Buy
58,754
+35
+0.1% +$4.25K 3.2% 5
2025
Q3 		$6.52M Sell
58,719
-1,609
-3% -$183K 3.01% 5
2025
Q2 		$6.69M Sell
60,328
-2,188
-3% -$233K 4.07% 3
2025
Q1 		$7M Sell
62,516
-12,780
-17% -$1.32M 4.72% 2
2024
Q4 		$6.96M Buy
75,296
+426
+0.6% +$38.4K 4.46% 2
2024
Q3 		$6.28M Sell
74,870
-1,340
-2% -$102K 4.04% 3
2024
Q2 		$5.23M Sell
76,210
-114
-0.1% -$7.61K 3.57% 5
2024
Q1 		$5.59M Buy
76,324
+613
+0.8% +$47.1K 3.78% 5
2023
Q4 		$6.13M Sell
75,711
-2,920
-4% -$227K 4.2% 3
2023
Q3 		$5.89M Buy
78,631
+609
+0.8% +$46.8K 4.34% 3
2023
Q2 		$6.01M Buy
78,022
+598
+0.8% +$47.7K 4.27% 3
2023
Q1 		$6.42M Buy
77,424
+553
+0.7% +$45.8K 4.79% 3
2022
Q4 		$6.6M Buy
76,871
+457
+0.6% +$36.2K 5.08% 3
2022
Q3 		$4.71M Sell
76,414
-144,709
-65% -$9.13M 3.8% 4
2022
Q2 		$20.3M Buy
221,123
+127,024
+135% +$7.86M 14.68% 1
2022
Q1 		$5.59M Buy
94,099
+1,216
+1% +$77.7K 3.16% 6
2021
Q4 		$6.74M Buy
92,883
+61
+0.1% +$4.2K 3.6% 4
2021
Q3 		$6.48M Buy
92,822
+472
+0.5% +$33.2K 3.81% 6
2021
Q2 		$6.36M Sell
92,350
-4,702
-5% -$314K 3.54% 7
2021
Q1 		$6.27M Sell
97,052
-1,393
-1% -$89.8K 3.86% 6
2020
Q4 		$5.74M Buy
+98,445
New +$5.94M 4.1% 6

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Twin Lakes Capital Management's GILD Position: Q2 2026 in Review

Twin Lakes Capital Management increased its Gilead Sciences (GILD) stake by 0.28% in Q2 2026, buying an estimated $21.7K and bringing the position to 58,267 shares worth $7.36M. The position accounts for 2.81% of the portfolio, ranked #5.

Twin Lakes Capital Management first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $20.3M in Q2 2022. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Twin Lakes Capital Management held 58,267 shares of Gilead Sciences worth $7.36M as of Q2 2026.
  • Twin Lakes Capital Management bought 165 Gilead Sciences shares in Q2 2026, an estimated $21.7K.
  • Gilead Sciences made up 2.81% of Twin Lakes Capital Management's portfolio in Q2 2026, its #5 holding.
  • Twin Lakes Capital Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • Twin Lakes Capital Management's Gilead Sciences position peaked at $20.3M in Q2 2022.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Twin Lakes Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.